Clinicopathologic characteristics of different molecular subtypes in TMBC patients.
收藏NIAID Data Ecosystem2026-03-09 收录
数据链接：
官方服务：
资源简介：
*Difference exists between subgroups; Luminal vs. Triple-negative, MD (Mean Difference) = 7.55, P = 0.002. Luminal vs. HER-2 overexpression, MD = 4.05, P = 0.212. Luminal vs. Unknown, MD = 1.61, P = 0.689. Triple-negative vs. HER-2 overexpression, MD = −3.50, P = 0.258. Triple-negative vs. Unknown, MD = −5.94, P = 0.129. HER-2 overexpression vs. Unknown, MD = −2.44, P = 0.583. Clinicopathologic characteristics of different molecular subtypes in TMBC patients.
创建时间：
2014-11-06
